Pharmaceutical Implant Manufacturing: Precision in Core and Shell Structures
Pharmaceutical Implant Manufacturing: Advanced Precision for Controlled Drug Delivery
Our partner is an advancing implant manufacturer with a recent project dedicated to achieving exceptional precision in core and shell structures. This initiative focused on producing vaginal and subcutaneous implants designed to provide reliable and controlled drug release over a defined period, ensuring therapeutic efficacy and patient safety.
Key Objectives and Scope
• Dimensional Accuracy: Achieving precise control of both the core and outer shell diameters to ensure consistent performance and predictable release rates.
• Controlled Drug Release: Developing implant structures that guarantee steady and reliable drug delivery over the required treatment duration, essential for maintaining efficacy.
• Process Optimization:
• Integration of a melt pump to maintain tight tolerances during extrusion, ensuring consistent quality across all implants.
• Introduction of a fully automated welding system to seamlessly join cut filaments into rings, enhancing accuracy and production efficiency.
• Regulatory and Quality Compliance: Ensuring adherence to pharmaceutical manufacturing standards to meet rigorous quality and safety requirements.
Successful Outcomes
• The entire process, from initial trials through component design to final production and commissioning, was completed smoothly and successfully.
• Precision manufacturing has enabled applications in various implant types, including vaginal, subcutaneous, and muscular implants, tailored to meet specific therapeutic needs.
Applications and Focus
These implants are designed for use in controlled-release therapies, where predictable and sustained drug delivery is crucial. Gedeon Richter’s focus on dimensional precision, automation, and compliance ensures the implants deliver consistent therapeutic outcomes, reinforcing the company’s position as a leader in advanced pharmaceutical technologies.
